vs
1stdibs.com, Inc.（DIBS）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是1stdibs.com, Inc.的1.5倍（$35.5M vs $23.0M），1stdibs.com, Inc.净利率更高（-4.5% vs -304.2%，领先299.7%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 0.9%），1stdibs.com, Inc.自由现金流更多（$3.6M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 2.0%）
1stdibs.com, Inc.是一家美国电商企业，运营线上奢侈品交易平台，主营室内设计高端家具、艺术藏品、珠宝等高端商品。品牌最初创立于巴黎，现总部设于纽约，凭借推动古董行业迈入21世纪的创新举措获得业内认可。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
DIBS vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.5倍
$23.0M
营收增速更快
RXRX
高出680.9%
0.9%
净利率更高
DIBS
高出299.7%
-304.2%
自由现金流更多
DIBS
多$50.9M
$-47.3M
两年增速更快
RXRX
近两年复合增速
2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $23.0M | $35.5M |
| 净利润 | $-1.0M | $-108.1M |
| 毛利率 | 73.5% | 59.8% |
| 营业利润率 | -10.1% | -304.8% |
| 净利率 | -4.5% | -304.2% |
| 营收同比 | 0.9% | 681.7% |
| 净利润同比 | 80.0% | 39.6% |
| 每股收益（稀释后） | $-0.02 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DIBSRXRX
| Q4 25 | $23.0M | $35.5M | ||
| Q3 25 | $22.0M | $5.2M | ||
| Q2 25 | $22.1M | $19.2M | ||
| Q1 25 | $22.5M | $14.7M | ||
| Q4 24 | $22.8M | $4.5M | ||
| Q3 24 | $21.2M | $26.1M | ||
| Q2 24 | $22.2M | $14.4M | ||
| Q1 24 | $22.1M | $13.8M |
净利润DIBSRXRX
| Q4 25 | $-1.0M | $-108.1M | ||
| Q3 25 | $-3.5M | $-162.3M | ||
| Q2 25 | $-4.3M | $-171.9M | ||
| Q1 25 | $-4.8M | $-202.5M | ||
| Q4 24 | $-5.2M | $-178.9M | ||
| Q3 24 | $-5.7M | $-95.8M | ||
| Q2 24 | $-4.4M | $-97.5M | ||
| Q1 24 | $-3.3M | $-91.4M |
毛利率DIBSRXRX
| Q4 25 | 73.5% | 59.8% | ||
| Q3 25 | 74.3% | -183.8% | ||
| Q2 25 | 71.8% | -4.9% | ||
| Q1 25 | 72.4% | -48.0% | ||
| Q4 24 | 72.3% | -181.4% | ||
| Q3 24 | 71.0% | 53.7% | ||
| Q2 24 | 71.7% | 36.2% | ||
| Q1 24 | 72.5% | 19.1% |
营业利润率DIBSRXRX
| Q4 25 | -10.1% | -304.8% | ||
| Q3 25 | -21.3% | -3327.6% | ||
| Q2 25 | -25.8% | -916.8% | ||
| Q1 25 | -27.7% | -1297.9% | ||
| Q4 24 | -30.6% | -4042.4% | ||
| Q3 24 | -34.9% | -377.1% | ||
| Q2 24 | -29.2% | -697.4% | ||
| Q1 24 | -24.3% | -698.4% |
净利率DIBSRXRX
| Q4 25 | -4.5% | -304.2% | ||
| Q3 25 | -16.0% | -3135.3% | ||
| Q2 25 | -19.5% | -894.2% | ||
| Q1 25 | -21.3% | -1373.3% | ||
| Q4 24 | -22.9% | -3935.5% | ||
| Q3 24 | -26.8% | -367.5% | ||
| Q2 24 | -20.0% | -676.6% | ||
| Q1 24 | -15.0% | -662.4% |
每股收益（稀释后）DIBSRXRX
| Q4 25 | $-0.02 | $-0.17 | ||
| Q3 25 | $-0.10 | $-0.36 | ||
| Q2 25 | $-0.12 | $-0.41 | ||
| Q1 25 | $-0.14 | $-0.50 | ||
| Q4 24 | $-0.14 | $-0.56 | ||
| Q3 24 | $-0.15 | $-0.34 | ||
| Q2 24 | $-0.12 | $-0.40 | ||
| Q1 24 | $-0.08 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.9M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $93.6M | $1.1B |
| 总资产 | $132.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资DIBSRXRX
| Q4 25 | $22.9M | $743.3M | ||
| Q3 25 | $19.9M | $659.8M | ||
| Q2 25 | $22.4M | $525.1M | ||
| Q1 25 | $20.3M | $500.5M | ||
| Q4 24 | $26.0M | $594.4M | ||
| Q3 24 | $22.0M | $427.6M | ||
| Q2 24 | $23.8M | $474.3M | ||
| Q1 24 | $33.7M | $296.3M |
总债务DIBSRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益DIBSRXRX
| Q4 25 | $93.6M | $1.1B | ||
| Q3 25 | $94.0M | $1.0B | ||
| Q2 25 | $94.9M | $919.1M | ||
| Q1 25 | $96.2M | $933.9M | ||
| Q4 24 | $99.3M | $1.0B | ||
| Q3 24 | $107.2M | $524.6M | ||
| Q2 24 | $110.4M | $584.4M | ||
| Q1 24 | $131.0M | $401.2M |
总资产DIBSRXRX
| Q4 25 | $132.1M | $1.5B | ||
| Q3 25 | $135.2M | $1.4B | ||
| Q2 25 | $138.6M | $1.3B | ||
| Q1 25 | $142.5M | $1.3B | ||
| Q4 24 | $145.8M | $1.4B | ||
| Q3 24 | $154.4M | $726.5M | ||
| Q2 24 | $157.6M | $775.9M | ||
| Q1 24 | $179.5M | $557.8M |
负债/权益比DIBSRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.3M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $3.6M | $-47.3M |
| 自由现金流率自由现金流/营收 | 15.7% | -133.1% |
| 资本支出强度资本支出/营收 | 2.9% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-3.2M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流DIBSRXRX
| Q4 25 | $4.3M | $-46.1M | ||
| Q3 25 | $-1.5M | $-117.4M | ||
| Q2 25 | $-5.1M | $-76.4M | ||
| Q1 25 | $-96.0K | $-132.0M | ||
| Q4 24 | $2.8M | $-115.4M | ||
| Q3 24 | $-3.0K | $-59.2M | ||
| Q2 24 | $-2.6M | $-82.2M | ||
| Q1 24 | $-3.1M | $-102.3M |
自由现金流DIBSRXRX
| Q4 25 | $3.6M | $-47.3M | ||
| Q3 25 | $-1.5M | $-117.6M | ||
| Q2 25 | $-5.2M | $-79.6M | ||
| Q1 25 | $-143.0K | $-133.8M | ||
| Q4 24 | $1.5M | $-116.7M | ||
| Q3 24 | $-44.0K | $-63.8M | ||
| Q2 24 | $-3.0M | $-83.4M | ||
| Q1 24 | $-3.3M | $-109.0M |
自由现金流率DIBSRXRX
| Q4 25 | 15.7% | -133.1% | ||
| Q3 25 | -6.8% | -2272.5% | ||
| Q2 25 | -23.4% | -413.9% | ||
| Q1 25 | -0.6% | -907.4% | ||
| Q4 24 | 6.5% | -2567.7% | ||
| Q3 24 | -0.2% | -244.6% | ||
| Q2 24 | -13.5% | -578.5% | ||
| Q1 24 | -14.8% | -789.9% |
资本支出强度DIBSRXRX
| Q4 25 | 2.9% | 3.5% | ||
| Q3 25 | 0.1% | 4.7% | ||
| Q2 25 | 0.2% | 16.4% | ||
| Q1 25 | 0.2% | 12.4% | ||
| Q4 24 | 5.8% | 28.6% | ||
| Q3 24 | 0.2% | 17.5% | ||
| Q2 24 | 1.6% | 8.2% | ||
| Q1 24 | 0.9% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
